Insider · CIK 0001236489

HUMMEL ALBERT F

Reports to the SEC for 3 companies · LONG BEACH, CA

sec.gov

Transactions

Companies

Filings

CIK

0001236489

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-09-16	Allergan Finance LLCG Gift	Director	GGift	−3,800 sh	—	—	88,976
2013-10-01	Allergan Finance LLCD Disposition to Issuer	Director	DDisposition to Issuer	−82.8K sh	—	—	0
2013-09-16	Allergan Finance LLCS Sale	Director	SSale	−6,200 sh	$137.81	−$854K	82,776
2013-08-26	Allergan Finance LLCS Sale	Director	SSale	−16K sh	$134.44	−$2.15M	92,776
2013-08-23	Allergan Finance LLCS Sale	Director	SSale	−4,044 sh	$134.16	−$543K	108,732
2013-08-22	Allergan Finance LLCS Sale	Director	SSale	−20K sh	$134.50	−$2.69M	112,776
2013-08-13	Allergan Finance LLCS Sale	Director	SSale	−10K sh	$133.85	−$1.34M	132,776
2013-08-13	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2013-08-13	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2013-08-13	Allergan Finance LLCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$29.03	+$145K	137,776
2013-08-13	Allergan Finance LLCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$30.12	+$151K	142,776
2013-05-10	Allergan Finance LLCA Award	Director	AAward	+1,877 sh	—	—	132,776
2013-04-25	Obagi Medical Products, Inc.Stock option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−100K sh	$11.45	−$1.15M	0
2013-04-25	Obagi Medical Products, Inc.Stock option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−165K sh	$11.30	−$1.86M	0
2013-04-25	Obagi Medical Products, Inc.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−65.8K sh	$24.00	−$1.58M	0
2012-05-29	Allergan Finance LLCS Sale	Director	SSale	−19K sh	$73.74	−$1.4M	130,899
2012-05-11	Allergan Finance LLCA Award	Director	AAward	+2,887 sh	—	—	149,899
2012-05-02	Allergan Finance LLCS Sale	Director	SSale	−10.7K sh	$74.73	−$798K	147,012
2012-05-02	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2012-05-02	Allergan Finance LLCM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$26.60	+$798K	157,691
2012-05-01	Obagi Medical Products, Inc.Stock OptionA Award	Director, President & CEO	AAward	+165K sh	—	—	265,000
2011-09-16	Allergan Finance LLCS Sale	Director	SSale	−10K sh	$67.25	−$673K	127,691
2011-05-13	Allergan Finance LLCA Award	Director	AAward	+3,177 sh	—	—	137,691
2011-05-06	Allergan Finance LLCS Sale	Director	SSale	−15K sh	$63.36	−$950K	134,514
2011-04-21	Obagi Medical Products, Inc.A Award	Director, President & CEO	AAward	+50K sh	—	—	65,787
2011-04-21	Obagi Medical Products, Inc.Stock OptionA Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2010-08-24	Allergan Finance LLCS Sale	Director	SSale	−20K sh	$42.07	−$841K	149,514
2010-06-08	Obagi Medical Products, Inc.A Award	Director, President & CEO	AAward	+2,463 sh	—	—	15,787
2010-05-07	Allergan Finance LLCA Award	Director	AAward	+5,000 sh	—	—	169,514
2009-06-18	Obagi Medical Products, Inc.A Award	Director, President & CEO	AAward	+4,055 sh	—	—	13,324
2009-05-08	Allergan Finance LLCA Award	Director	AAward	+5,000 sh	—	—	164,514
2007-06-07	Obagi Medical Products, Inc.A Award	Director, President & CEO	AAward	+1,023 sh	—	—	5,812
2007-04-18	Obagi Medical Products, Inc.A Award	Director, President & CEO	AAward	+2,289 sh	—	—	4,789
2005-06-29	Allergan Finance LLCNon-Qualified Options to Purchase Common StockA Award	Director	AAward	+5,000 sh	—	—	5,000
2005-06-29	Allergan Finance LLCA Award	Director	AAward	+1,667 sh	—	—	149,513

Recent filings

Accepted (ET)
Oct 24
Actavis, Inc.0001179110-13-015063
SEC(opens sec.gov)
Sep 184
Actavis, Inc.0001179110-13-014324
SEC(opens sec.gov)
Aug 264
Actavis, Inc.0001179110-13-013491
SEC(opens sec.gov)
Aug 154
Actavis, Inc.0001179110-13-013192
SEC(opens sec.gov)
May 144
HUMMEL ALBERT F0001179110-13-008358
SEC(opens sec.gov)
Apr 294
HUMMEL ALBERT F0001140361-13-017685
SEC(opens sec.gov)
May 294
HUMMEL ALBERT F0001179110-12-009295
SEC(opens sec.gov)
May 144
HUMMEL ALBERT F0001179110-12-008402
SEC(opens sec.gov)
May 44
HUMMEL ALBERT F0001179110-12-007747
SEC(opens sec.gov)

Companies

Address

C/O OBAGI MEDICAL PRODUCTS, INC 3760 KILROY AIRPORT WAY SUITE 500

LONG BEACH, CA, 90806